INTRODUCTION
Coronary artery disease (CAD) is the main cause of mortality and morbidity among patients with impaired renal function. Their mortality is 15 to 30 times higher than the ageadjusted cardiovascular (CV) mortality in the general population. Left ventricular size is also a known risk factor of CV mortality. 5 The prevalence of mild-to-moderate chronic kidney disease (CKD) in US is 42 -60%.
There is evidence in pediatric population that cardiac changes may begin during mild-tomoderate CKD. 8 Changes in cardiac structure are well-established in individuals with coronary artery disease. Thus, it has been speculated that cardiac remodeling in renal disease patients is a result of atherosclerotic disease. 11 A knowledge gap exists regarding establishing these changes in mild-to-moderate CKD individuals without known CAD.
The relationship between mild-to-moderate CKD and cardiac structure can be elucidated by using non-contrast computed tomography (CT) and magnetic resonance imaging derived left ventricular (LV) volume and LV mass. We have previously showed that non -contrast CT used for obtaining for coronary calcium score may provide reliable estimate of LV size. 12 Understanding the relationship of cardiac structure and mild-to-moderate CKD may provide us insight into underlying mechanisms leading to cardiac remodeling. We investigated association of mild-to-moderate CKD and changes in CT derived LV (CTLV) size.
METHODS

Study population and design
The Multi-Ethnic Study of Atherosclerosis (MESA) investigated the prevalence, correlates, and progression of subclinical cardiovascular disease (CVD) in a population-based sample of 6,814 men and women aged 45-84 years from 4 racial/ethnic backgrounds (Whites, Asians, Blacks and Hispanics) that were free of known cardiovascular disease at baseline. The study objectives and design have been published before. 13 Briefly, this prospective cohort study recruited individuals from six U.S. communities (Baltimore, Maryland; Chicago, Illinois; Forsyth County, North Carolina; Los Angeles County, California; northern Manhattan, New York; and St.
Paul, Minnesota). In this analysis, we included all individuals who had baseline LV size assessment on non-contrast computed tomography. We used baseline data from MESA (Jul 2000 -Jul 2002). A total of 6,753 individuals formed the study cohort in whom CTLV sizes were available. Institutional Review Board approval was obtained at all MESA sites, and written informed consent obtained from all individuals. Individuals with eGFR <30 ml/min (n = 33) were excluded.
Covariate assessment
Medical history, anthropometric measurements, and laboratory data for the present study were taken from the first examination of the MESA cohort (July 2000 to August 2002).
Information about age, sex, race/ethnicity, and medical history were obtained by questionnaires.
Years of tobacco smoking were obtained by self-report. Diabetes mellitus (DM) was defined as a fasting glucose >126 mg/dL or use of hypoglycemic medications. Resting blood pressure was measured 3 times in the seated position, and the average of the second and third readings was Mild-to-moderate CKD was defined as eGFR from 30 -90 ml/min. Details for feasibility, development of methodology and determination of LVS have been described previously. Briefly, LVS was defined as total LV volume which is actually the sum of LV mass and LV intracavitary volume. This can be calculated from trigonometry formula for volume of a cone. Thus, LVS is simply LV area (A) multiplied with LV height (H). LV height is obtained by multiplying the number of slices required to cover the whole LV myocardium with thickness of each slice. LV area was calculated using a single slice obtained at the level containing the coronary sinus or the first level below the left atrium during mid-diastole.
Left ventricular size by non-contrast computed tomography (CTLV)
For measuring LV area, a straight line was drawn from anterior interventricular groove to the posterior interventricular groove. The anterior interventricular groove was determined by natural markers such as an abrupt dip between both ventricles anteriorly which represents fat tissue or a high density circular image which represents cross-section of left anterior descending artery. The posterior interventricular groove was determined by groove present in the area where coronary sinus enters right atrium. The next step was to trace the outer border of left ventricle to obtain LV area. LVS was then calculated by the following formula described by Mao et al. 16 This formula was obtained from linear regression model that used A and H calculated from contrast enhanced cardiac CT. This formula has shown excellent correlation with LVS obtained from NCCT 
Statistical analysis
For descriptive analysis continuous variables were presented as mean ± standard deviations and were compared using Student's t -test. Categorical data was presented as percentages, which were compared by using chi -square test or non-parametric Mann Whitney U test depending upon the normality of variable's distribution. CTLV and MRLV sizes were dichotomized into 4 th quartile and 1-3 rd quartile groups. Estimated GFR was analyzed both as dichotomous variable with cut off as 90 ml/min. We assessed relationship of 4 th quartile of CTLV size with CKD eGFR ≤90 ml/min vs. non-CKD eGFR >90 ml/min in univariate and multivariable logistic regression models. We constructed two models, model 1 adjusted for demographics (age, sex, race/ethnicity) and model 2 adjusted in addition to demographics, body mass index, hypertension, diabetes, cigarette pack years of smoking, LDL cholesterol levels, and cholesterol lowering medications. We evaluated similar univariate and multivariable models for MRLV size.
We also constructed univariate and multivariable linear regression models to assess relationship of eGFR with LV mass and averaged LV volume. Multivariable regression models were adjusted for model 1 and model 2 (given above). Averaged LV volume was calculated by averaging LV end-systolic and end-diastolic volumes. Correlation between CTLV size and MRLV size was assessed. Scatter plots with correlation coefficient were also constructed. Interactions of eGFR with age, sex and race/ethnicity were tested. Statistical analyses were performed using JMP v.
(SAS Inc, Cary, NC).
RESULTS
A total of 6,753 individuals in whom CTLV size was available were included in the primary analysis. MRLV size was available 4982 individuals. The correlation between CTLV size and MRLV size was 0.79, p <0.001. There were 83% individuals with mild-to-moderate CKD. The individuals with CKD were more likely to be older, hypertensive, diabetic, and smokers compared to non CKD participants ( Table 1) . The mean CTLV size was 188±57 cm Table   2 ). Individuals with eGFR ≤90 ml/min had lower proportion of highest quartile of CTLV size (Figure 1 ). There were no significant interactions for age, sex and race/ethnicity observed.
In univariate linear regression model, eGFR was directly associated with averaged LV volume and LV mass ( Table 3) . However, when linear regression model was adjusted for demographics and potential confounders, the significant association of eGFR with averaged LV volume disappeared but the association with LV mass remained significant (p = 0.01). There was a linear association of eGFR with CTLV size and MRLV size is shown in scatter plots (Figure 3 ).
There were no significant interactions for age, sex and race/ethnicity observed.
DISCUSSION
In this study, we evaluated the independent relationship of mild-to-moderate renal dysfunction (CKD stage 2 and 3) with non-contrast CT based LV size and MRI based LV size.
We demonstrated that eGFR was significantly positively associated with LV size irrespective of modality of measurement. On further exploratory analysis, this association was mainly determined by LV mass rather than LV volumes.
To the best of our knowledge, this is the first study showing association of renal function with left ventricular size using a single section of non-contrast CT. We have also extended previous findings by demonstrating an effect on left ventricle size among individuals with milder renal impairment. Previous literature has shown similar association among moderate to severe forms of CKD (CKD stage >3). [18] [19] [20] Prior literature suggests coronary artery disease as a possible causative factor in development of these changes in renal disease patients. The participants of this cohort were rigorously screened for coronary artery disease prior to enrollment and represent individuals without known coronary artery disease. Thus, suggesting that there are mechanisms other than coronary artery disease at play in renal disease patients that lead to cardiac changes.
When we investigated the relationship of renal disease with MR derived LV mass and LV volumes, we found that the association of GFR was stronger for LV mass than LV volumes. Prior studies have studied LV mass and LV volumes in isolation [18] [19] [20] and have suggested that left ventricular function decreases with progression of renal disease and there is progressive dilatation of LV. [21] [22] [23] We observed that this may not be true in individuals with mild-to-moderate CKD. We also observed that LV mass was directly associated with eGFR rather than inversely as observed 7 in studies with moderate to severe CKD. Thus, there is a likely possibility of J shaped nonlinear association of eGFR with LV structural changes which further remains to be investigated in future studies.
There are many possible mechanisms that may explain this observation. It is possible that loss of functioning myocardium in mild -moderate CKD and replacement fibrosis may lead to reduction in LV mass and size. 26 In a rodent model of mild renal insufficiency, dUTP nick-end labeling (TUNEL) staining revealed increased apoptosis and loss of myocardium. 26 There is an early increase in intravascular volume of mild-to-moderate CKD in the presence of activated renin-angiotensin-aldosterone system. 27 This may lead to remodeling in the early phase of CKD.
However, much remains to be still investigated in the realm of mild CKD.
There are several implications of this study. This study documents strong association of non-contrast CT measured LV size with mild-to-moderate CKD which may provide a nondiagnostic test to detect early cardiac changes in these patients. Also, the study suggests that mildto-moderate CKD might not be benign since this might be the time when reversibility of many of these cardiac changes can occur. However, currently these patients are cared by general internists where management of risk factors of cardiovascular disease is the main choice of treatment. The individuals in this study were relatively at lower risk of cardiovascular disease but still had cardiac structural changes. A rigorous approach towards detection of cardiac structural changes is not currently considered in these patients however, data from other studies have shown that early treatment of reversible causes of cardiac structural changes results in improved survival. [28] [29] [30] There are several strengths of the study such as large sample size, uniform and robust methods used to obtain NCCTs, no missing values, multi-ethnic and adequately powered study to analyze the small effect of mild -to -moderate renal disease on LV size. There are several limitations worth mentioning. We calculated LV size from a single slice of NCCT. Individuals with cardiomyopathy have severely deformed left ventricles, and this might lead to a systematic error. However, MESA cohort individuals were screened at the baseline for cardiomyopathies and none of the individuals suffered from a known cardiomyopathy detectable by MRI at baseline.
CTLV size also ignores delineation between LV volumes and LV mass thus, causing difficulty to assess separate effects. However, we included data from calculated MRLV size to explain the 8 associations of renal disease with measures of cardiac structure. Also, prognosis of CTLV size is not included in this study and will be subject of a future study.
In conclusion, this study shows direct association of renal function with LV size in individuals free of cardiovascular disease. This association was consistent for LV size measured by non-contrast CT as well as cardiac MRI. We also found that association of renal function was stronger for LV mass than LV volumes. Further studies are required to delineate the causal pathway and directionality of this cross-sectional association.
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